These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 28417500)

  • 1. Editorial: hepatitis B reactivation in patients with chronic hepatitis C treated with direct-acting antivirals - incidence, severity of hepatitis and lessons to learn.
    Chen CH
    Aliment Pharmacol Ther; 2017 May; 45(10):1373-1374. PubMed ID: 28417500
    [No Abstract]   [Full Text] [Related]  

  • 2. Reactivation of hepatitis B in patients of chronic hepatitis C with hepatitis B virus infection treated with direct acting antivirals.
    Yeh ML; Huang CF; Hsieh MH; Ko YM; Chen KY; Liu TW; Lin YH; Liang PC; Hsieh MY; Lin ZY; Chen SC; Huang CI; Huang JF; Kuo PL; Dai CY; Yu ML; Chuang WL
    J Gastroenterol Hepatol; 2017 Oct; 32(10):1754-1762. PubMed ID: 28230928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B reactivation in chronic hepatitis C patients treated with interferon or pan-oral direct-acting antivirals.
    Liu J
    Hepatology; 2018 Jan; 67(1):453-454. PubMed ID: 29080221
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatitis B virus reactivation after direct-acting antivirals for chronic hepatitis C infection.
    Thibault V
    Lancet Gastroenterol Hepatol; 2018 Mar; 3(3):145-147. PubMed ID: 29371018
    [No Abstract]   [Full Text] [Related]  

  • 5. Low incidence of hepatitis B virus reactivation and subsequent hepatitis in patients with chronic hepatitis C receiving direct-acting antiviral therapy.
    Tamori A; Abiru S; Enomoto H; Kioka K; Korenaga M; Tani J; Enomoto M; Sugiyama M; Masaki T; Kawada N; Yatsuhashi H; Nishiguchi S; Mizokami M
    J Viral Hepat; 2018 May; 25(5):608-611. PubMed ID: 29194858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No evidence of hepatitis B virus reactivation in patients with resolved infection treated with direct-acting antivirals for hepatitis C in a large real-world cohort.
    Mücke VT; Mücke MM; Peiffer KH; Weiler N; Welzel TM; Sarrazin C; Zeuzem S; Berger A; Vermehren J
    Aliment Pharmacol Ther; 2017 Aug; 46(4):432-439. PubMed ID: 28627791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of hepatitis B reactivation in patients treated with direct-acting antivirals for hepatitis C.
    Aggeletopoulou I; Konstantakis C; Manolakopoulos S; Triantos C
    World J Gastroenterol; 2017 Jun; 23(24):4317-4323. PubMed ID: 28706414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing the risk of hepatitis B virus reactivation between direct-acting antiviral therapies and interferon-based therapies for hepatitis C.
    Kawagishi N; Suda G; Onozawa M; Kimura M; Maehara O; Ohara M; Izumi T; Umemura M; Ito J; Nakai M; Sho T; Natsuizaka M; Morikawa K; Ogawa K; Sakamoto N
    J Viral Hepat; 2017 Dec; 24(12):1098-1106. PubMed ID: 28632923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of acute hepatitis B in a chronic hepatitis C patient after daclatasvir and asunaprevir combination therapy: hepatitis B virus reactivation or acute self-limited hepatitis?
    Hayashi K; Ishigami M; Ishizu Y; Kuzuya T; Honda T; Nishimura D; Goto H; Hirooka Y
    Clin J Gastroenterol; 2016 Aug; 9(4):252-6. PubMed ID: 27329484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Letter: hepatitis B reactivation in patients with chronic hepatitis C during direct-acting antiviral therapy-authors' reply.
    Londoño MC; Carrión JA; Forns X
    Aliment Pharmacol Ther; 2017 Jun; 45(12):1559-1560. PubMed ID: 28503869
    [No Abstract]   [Full Text] [Related]  

  • 11. Risk of hepatitis B virus reactivation in hepatitis B virus + hepatitis C virus-co-infected patients with compensated liver cirrhosis treated with ombitasvir, paritaprevir/r + dasabuvir + ribavirin.
    Preda CM; Popescu CP; Baicus C; Constantinescu I; Oproiu A; Voiosu T; Diculescu M; Negreanu L; Gheorghe L; Sporea I; Trifan A; Ceausu E; Proca D; Manuc M
    J Viral Hepat; 2018 Jul; 25(7):834-841. PubMed ID: 29397016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B Virus Reactivation Associated With Direct-Acting Antiviral Therapy for Chronic Hepatitis C Virus.
    Bersoff-Matcha SJ; Cao K; Jason M; Jones SC; Brinker A
    Ann Intern Med; 2017 Nov; 167(10):760. PubMed ID: 29159389
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of hepatitis B reactivation among 62,920 veterans treated with oral hepatitis C antivirals.
    Belperio PS; Shahoumian TA; Mole LA; Backus LI
    Hepatology; 2017 Jul; 66(1):27-36. PubMed ID: 28240789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B virus reactivation during direct-acting antiviral treatment of chronic hepatitis C: A hidden danger of an otherwise major success story.
    Perrillo RP
    Hepatology; 2017 Jul; 66(1):4-6. PubMed ID: 28370190
    [No Abstract]   [Full Text] [Related]  

  • 15. Letter: hepatitis B virus reactivation in patients with chronic hepatitis C during direct-acting anti-viral therapy.
    Huang R; Yan X; Xia J; Wang J; Wu C
    Aliment Pharmacol Ther; 2017 Jun; 45(12):1558. PubMed ID: 28503862
    [No Abstract]   [Full Text] [Related]  

  • 16. Letter: adoption of uniform nomenclature is crucial for estimating the true risk of HBV reactivation in patients treated with direct-acting antivirals for hepatitis C.
    Mücke MM; Mücke VT; Vermehren J
    Aliment Pharmacol Ther; 2018 Jun; 47(11):1573-1574. PubMed ID: 29878415
    [No Abstract]   [Full Text] [Related]  

  • 17. Fulminant hepatitis B reactivation leading to liver transplantation in a patient with chronic hepatitis C treated with simeprevir and sofosbuvir: a case report.
    Ende AR; Kim NH; Yeh MM; Harper J; Landis CS
    J Med Case Rep; 2015 Jul; 9():164. PubMed ID: 26215390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct-acting antiviral treatment in adults infected with hepatitis C virus: Reactivation of hepatitis B virus coinfection as a further challenge.
    De Monte A; Courjon J; Anty R; Cua E; Naqvi A; Mondain V; Cottalorda J; Ollier L; Giordanengo V
    J Clin Virol; 2016 May; 78():27-30. PubMed ID: 26967675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B reactivation in patients receiving direct-acting antiviral therapy or interferon-based therapy for hepatitis C: A systematic review and meta-analysis.
    Jiang XW; Ye JZ; Li YT; Li LJ
    World J Gastroenterol; 2018 Jul; 24(28):3181-3191. PubMed ID: 30065564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct-acting antivirals and hepatitis B virus (HBV) reactivation in co-infected HBV/HCV kidney-transplant recipients.
    Pol S; Marion O; Vallet-Pichard A; Meritet JF; Sauné K; Alric L; Kamar N
    Transpl Infect Dis; 2018 Jun; 20(3):e12864. PubMed ID: 29512231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.